The effect of hypoxia mimetic cobalt chloride on the expression of EC-SOD in 3T3-L1 adipocytes

Redox Report

Volumn 15, Issue 3, 2010, Pages 131-137

  Kamiya, Tetsuro ^a,b   Hara, Hirokazu ^a   Inagaki, Naoki ^b   Adachi, Tetsuo ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^b GIFU UNIVERSITY   (Japan)

Author keywords

adiponectin; c Jun N terminal kinase; cobalt chloride; extracellular superoxide dismutase; tumor necrosis factor alpha

Indexed keywords

ADIPONECTIN; COBALT CHLORIDE; EXTRACELLULAR SUPEROXIDE DISMUTASE; MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; 6-HYDROXY-2,5,7,8-TETRAMETHYLCHROMAN-2-CARBOXYLIC ACID; ANTIOXIDANT; CHROMAN DERIVATIVE; COBALT; ISOENZYME; SOD3 PROTEIN, MOUSE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR; TROLOX C;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL HYPOXIA; CELL STRAIN 3T3; CONTROLLED STUDY; METABOLIC DISORDER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; DOSE RESPONSE; DRUG EFFECT; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM;

3T3-L1 CELLS; ADIPOCYTES; ADIPONECTIN; ANIMALS; ANTIOXIDANTS; CELL HYPOXIA; CHROMANS; COBALT; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; ISOENZYMES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77954172713     PISSN: 13510002     EISSN: 17432928     Source Type: Journal    
DOI: 10.1179/174329210X12650506623483     Document Type: Article

References (34)

1. Eriksson JW. Metabolic stress in insulin's target cells leads to ROS accumulation - a hypothetical common pathway causing insulin resistance. FEBS Lett 2007; 581: 3734-3742.
2. Hotamisligil GS, Spiegelman BM. Tumor necrosis factor α: a key component of the obesity-diabetes link. Diabetes 1994; 43: 1271-1278.
3. Shimomura I, Funahashi T, Takahashi M et al. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med 1996; 2: 800-803.
4. Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 2002; 13: 84-89.
5. Havel PJ. Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes 2004; 53 Suppl. 1): S143-S151.
6. Yamauchi T, Kamon J, Minokoshi Y et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMPactivated protein kinase. Nat Med 2002; 8: 1288-1295. (Pubitemid 35373562)
7. Ouchi N, Kihara S, Arita Y et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999; 100: 2473-2476.
8. Arita Y, Kihara S, Ouchi N et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257: 79-83.
9. Hotta K, Funahashi T, Arita Y et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595-1599.
10. Kim KY, Kim JK, Jeon JH, Yoon SR, Choi I, Yang Y. c-Jun Nterminal kinase is involved in the suppression of adiponectin expression by TNF-αin 3T3-L1 adipocytes. Biochem Biophys Res Commun 2005; 327: 460-467.
11. Soares AF, Guichardant M, Cozzone D et al. Effects of oxidative stress on adiponectin secretion and lactate production in 3T3-L1 adipocytes. Free Radic Biol Med 2005; 38: 882-889.
12. Simons PJ, van den Pangaart PS, Aerts JM, Boon L. Proinflammatory delipidizing cytokines reduce adiponectin secretion from human adipocytes without affecting adiponectin oligomerization. J Endocrinol 2007; 192: 289-299.
13. Adachi T, Toishi T, Wu H, Kamiya T, Hara H. Expression of extracellular superoxide dismutase during adipose differentiation in 3T3-L1 cells. Redox Report 2009; 14: 34-40.
14. Brook CG, Lloyd JK, Wolf OH. Relation between age of onset of obesity and size and number of adipose cells. BMJ 1972; 2: 25-27.
15. Helmlinger G, Yuan F, Dellian M, Jain RK. Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat Med 1997; 3: 177-182.
16. Vincent F, Hagiwara K, Ke Y, Stoner GD, Demetrick DJ, Bennett WP. Mutation analysis of the transforming growth factor βtype II receptor in sporadic human cancers of the pancreas, liver, and breast. Biochem Biophys Res Commun 1996; 223: 561-564.
17. Lee PJ, Jiang BH, Chin BY et al. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J Biol Chem 1997; 272: 5375-5381.
18. Levy AP, Levy NS, Wegner S, Goldberg MA. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 1995; 270: 13333-13340.
19. Hosogai N, Fukuhara A, Oshima K et al. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 2007; 56: 901-911.
20. Schuster SJ, Badiavas EV, Costa-Giomi P, Weinmann R, Erslev AJ, Caro J. Stimulation of erythropoietin gene transcription during hypoxia and cobalt exposure. Blood 1989; 73: 13-16.
21. Furukawa S, Fujita T, Shimabukuro M et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114: 1752-1761.
22. Roberts CK, Barnard RJ, Sindhu RK, Jurczak M, Ehdaie A, Vaziri ND. Oxidative stress and dysregulation of NAD(P)H oxidase and antioxidant enzymes in diet-induced metabolic syndrome. Metabolism 2006; 55: 928-934.
23. Faraci FM, Didion SP. Vascular protection: superoxide dismutase isoforms in the vessel wall. Arterioscler Thromb Vasc Biol 2004; 24: 1367-1373.
24. Faraci FM. Vascular protection. Stroke 2003; 34: 327-329.
25. Marklund SL. Extracellular superoxide dismutase in human tissues and human cell lines. J Clin Invest 1984; 74: 1398-1403.
26. Adachi T, Inoue M, Hara H, Maehata E, Suzuki S. Relationship of plasma extracellular-superoxide dismutase level with insulin resistance in type 2 diabetic patients. J Endocrinol 2004; 181: 413-417.
27. Kamiya T, Hara H, Yamada H, Imai H, Inagaki N, Adachi T. Cobalt chloride decreases EC-SOD expression through intracellular ROS generation and p38-MAPK pathways in COS7 cells. Free Radic Res 2008; 42: 949-956.
28. Mori T, Sakaue H, Iguchi H et al. Role of Kruppel-like factor 15 (KLF15) in transcriptional regulation of adipogenesis. J Biol Chem 2005; 280: 12867-12875.
29. Ye J, Gao Z, Yin J, He Q. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol 2007; 293: E1118-E1128.
30. Adachi T, Toishi T, Takashima E, Hara H. Infliximab neutralizes the suppressive effect of TNF-αon expression of extracellularsuperoxide dismutase in vitro. Biol Pharm Bull 2006; 29: 2095-2098.
31. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Are oxidative stress-activated signaling pathways mediators of insulin resistance and β-cell dysfunction? Diabetes 2003; 52: 1-8.
32. Richard DE, Berra E, Gothie E, Roux D, Pouyssegur J. p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1α(HIF-1α) and enhance the transcriptional activity of HIF-1. J Biol Chem 1999; 274: 32631-32637.
33. Kyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 2001; 81: 807-869.
34. Pearson G, Robinson F, Beers Gibson T et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 2001; 22: 153-183.